{
  "nct_id": "NCT95266614",
  "indication": "Melanoma",
  "phase": "Phase 1",
  "sample_size": 25,
  "duration_weeks": 11,
  "dropout_rate": 0.15,
  "blinding": "open-label",
  "control_arm": "placebo",
  "primary_endpoints": [
    "Overall survival"
  ],
  "secondary_endpoints": [
    "Objective response rate",
    "Progression-free survival"
  ],
  "outcome_summary": "Did not meet primary efficacy endpoints",
  "success": 0,
  "failure_reason": "Inadequate statistical power",
  "start_date": "2021-02-01",
  "completion_date": "2021-04-19"
}